Skip to main content

2007 to 2020 Saw Continuous Decrease in Cervical Cancer in Younger Women

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 5, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Aug. 5, 2024 -- For individuals younger than 25 years, the incidence of cervical intraepithelial neoplasia (CIN) decreased continuously from 2007 through 2020, according to a research letter published online July 25 in JAMA Oncology.

Rachael Adcock, Ph.D., from the University of New Mexico Center for HPV Prevention in Albuquerque, and colleagues updated the previous report of the population-level incidence of CIN grades 1, 2, and 3 for individuals aged 15 to 29 years from 2007 through Dec. 31, 2020. Incidence rates were estimated annually per 100,000 individuals screened.

The researchers found a decrease in the incidence of CIN3 from 240.2 in 2007 to 0 in 2020 (annual percentage change [APC], −34.0 percent) among those aged 15 to 19 years. The corresponding decreases in CIN2 and CIN1 were 896.4 to 371.7 and 3,468.3 to 743.5, respectively. For individuals aged 20 to 24 years, the incidence of CIN3 decreased from 528.6 in 2007 to 325.2 in 2020 (APC, −5.8 percent); the corresponding decreases were 1,027.7 to 371.6 for CIN2 and 3,257.2 to 1,207.8 for CIN1. For those aged 25 to 29 years, increases were seen in the incidence of CIN3, CIN2, and CIN1 (from 437.9 to 985.9; 681.8 to 725.6; and from 2,092.4 to 2,484.4, respectively). The APC was only significant for CIN3, at 5.2 percent.

"If high HPV vaccination coverage is sustained, the age at which cervical screening initiation is recommended might be increased further and the number of lifetime cervical screens potentially reduced," the authors write.

One author disclosed ties to Hologic and Becton Dickinson.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Older Adults Have Low Knowledge of RSV Disease and Vaccine Eligibility

MONDAY, April 7, 2025 -- Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, according to a study published...

Zoster Vaccine Has Dementia-Preventing or Delaying Effect

THURSDAY, April 3, 2025 -- Zoster vaccination seems to have a dementia-preventing or dementia-delaying effect, according to a study published online April 2 in Nature. Markus...

Coverage for Routine Childhood Vaccines Remains Below Prepandemic Levels

WEDNESDAY, March 26, 2025 -- Three years after the start of the COVID-19 pandemic, coverage for selected routine childhood vaccines remained below prepandemic levels, according to...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.